Wenqun Li
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Pharmacology top 2%
- Pulmonary and Respiratory Medicine
- Cancer Research top 10%
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (15 papers)MicroRNA in disease regulation (6 papers)Inflammasome and immune disorders (6 papers)
In The Last Decade
Wenqun Li
57 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 712
- Cardiology and Cardiovascular Medicine 272
- Pharmacology 176
- Pulmonary and Respiratory Medicine 166
- Cancer Research 163
Countries citing papers authored by Wenqun Li
This map shows the geographic impact of Wenqun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqun Li more than expected).
Fields of papers citing papers by Wenqun Li
This network shows the impact of papers produced by Wenqun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqun Li. The network helps show where Wenqun Li may publish in the future.
Co-authorship network of co-authors of Wenqun Li
This figure shows the co-authorship network connecting the top 25 collaborators of Wenqun Li. A scholar is included among the top collaborators of Wenqun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqun Li. Wenqun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 8 | |
| 9 | 4 | |
| 10 | 12 | |
| 11 | 12 | |
| 12 | 4 | |
| 13 | 37 | |
| 14 | Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitisbreakdown → | 164 |
| 15 | 6 | |
| 16 | 18 | |
| 17 | 119 | |
| 18 | 38 | |
| 19 | 28 | |
| 20 | 9 |
About Wenqun Li
Wenqun Li is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (15 papers), MicroRNA in disease regulation (6 papers) and Inflammasome and immune disorders (6 papers). The work is most often cited by research in Pharmacology (176 citations), Complementary and alternative medicine (131 citations) and Biological Psychiatry (32 citations). Wenqun Li has collaborated with scholars based in China and Poland. Frequent co-authors include Bikui Zhang, Shanshan Wei, Wanjun Ma, Taoli Sun, Weijun Peng, Chuanhao Jiang, Jiaqin Liu, Yuan‐Jian Li, Daxiong Xiang and Xiaohui Li. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.